| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3B | $4.6B | $4.1B | $3.6B | $3.0B | $2.7B | $2.3B | $2.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.5B | $1.4B | $1.3B | $1.1B | $0.8B | $0.6B | $0.5B | $0.4B |
| Net Income | $1.1B | $1.1B | $1.0B | $0.8B | $0.7B | $0.6B | $1.0B | $0.3B |
| EPS (Basic) | $4.09 | $3.89 | $3.86 | $3.13 | $2.54 | $2.16 | $3.62 | $1.26 |
| EPS (Diluted) | $4.06 | $3.85 | $3.82 | $3.09 | $2.50 | $2.11 | $3.53 | $1.23 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.2B | $9.0B | $5.7B | $5.1B | $4.4B | $4.0B | $3.4B | $2.5B |
| Current Assets | $4.7B | $4.0B | $2.0B | $1.7B | $1.7B | $1.5B | $1.2B | $1.0B |
| Cash & Equivalents | $3.0B | $2.6B | $1.0B | $0.9B | $1.1B | $0.9B | $0.7B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.6B | $1.4B | $1.6B | $1.3B | $1.0B | $0.8B | $0.7B | $0.7B |
| Stockholders' Equity | $5.5B | $4.7B | $3.4B | $2.7B | $2.7B | $2.5B | $2.1B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.7B | $1.3B | $1.3B | $1.2B | $1.1B | $0.9B | $0.7B | $0.6B |
| Investing Cash Flow | $-0.5B | $-0.8B | $-0.4B | $-0.7B | $-0.3B | $-0.3B | $-0.1B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.9B | $1.2B | $-0.8B | $-0.7B | $-0.6B | $-0.4B | $-0.4B | $-0.6B |